Pathology and Oncology Informatics Opportunities and Threats APIII 2005, Lake Tahoe, CA Friday, Augu - PowerPoint PPT Presentation

1 / 52
About This Presentation
Title:

Pathology and Oncology Informatics Opportunities and Threats APIII 2005, Lake Tahoe, CA Friday, Augu

Description:

Pathology and Oncology Informatics Opportunities and Threats APIII 2005, Lake Tahoe, CA Friday, Augu – PowerPoint PPT presentation

Number of Views:218
Avg rating:3.0/5.0
Slides: 53
Provided by: johns112
Category:

less

Transcript and Presenter's Notes

Title: Pathology and Oncology Informatics Opportunities and Threats APIII 2005, Lake Tahoe, CA Friday, Augu


1
Pathology and Oncology InformaticsOpportunities
and Threats APIII 2005, Lake Tahoe, CA Friday,
August 26th, 2005
  • Michael J. Becich, MD PhD (becich_at_pitt.edu)
  • Vice Chairman of Pathology,
  • Professor of Pathology, Info Sciences
    Telecommunications
  • University of Pittsburgh School Medicine
  • Director, Center for Pathology Informatics
  • http//path.upmc.edu/cpi
  • Course Co-Director, Advancing Practice,
    Instruction and
  • Innovation through Informatics
    (http//apiii.upmc.edu)
  • Ad Hoc Councilor, Association for Pathology
    Informatics
  • http//www.pathologyinformatics.org

2
Disclosures by MJB Team
  • Corporate Support for API and APIII
  • 650K projected for 2005 Cerner, Misys, IMPAC CAP
    Today, Cisco, Verizon, AACI, Aperio, Apollo,
    Applied Bioinformatics, Ardais, Bayer Healthcare,
    Beckman Coulter, Bioimagine, DakoCytomation,
    Chromavision, GE/Amersham Biosciences, General
    Data, Humintec, InterScope Technologies, Nikon,
    Olympus, PSA, Psyche, Roche Diagnostics,
    ScanSoft, SCC Soft Computing, Synchroscopy,
    SNOMED, Taylor Data, Thermo Shandon, Trestle and
    Voicebrook and others
  • Corporate Sponsored Research Agreements
  • 3.0M in 2005 Amgen, Ardais Corp, Aurora
    Interactive, IBM, Cerner, Misys, Nikon, Olympus,
    Pittsburgh Life Sciences Green House, Sequel
    Genetics Trestle Corp.
  • Startup/Public Companies (Founder, Equity
    Consultant)
  • InterScope Technologies, Inc. -
    http//www.interscopetech.com
  • Member of the Board of Directors, Paid Consultant
  • Provider of high speed/volume whole slide
    imaging/telepathology systems
  • Ultrarapid whole slide imaging Gb data
    transfers, terabyte storage and robotics
  • Icoria (NASDAQ ICOR) formerly Paradigm Genetics
    merged with TissueInformatics, Inc., 03/04,
    http//www.icoria.com
  • Systems biology as a CRO to pharma, agra and
    biotech venture backed TVM, Motorola.
  • Hyperquantitative image analysis, genomics and
    bioinformatics capabilities.
  • Consultancies (in addition to Trestle Corp.)
  • Pathology Education Consortium (PEC) with Bruce
    Friedman (volunteer)
  • Misys Strategic Planning Group and Physician
    Advisory Board (paid)
  • ThermoElectron Physician Advisory Board (paid)

3
Outline
  • SWOT Analysis for Pathology Informatics
  • Strengths Imaging and Tissue Banking
  • Strengths - 70 of data in EMR/70 of medical
    decisions 3 budget
  • Strengths - recycle opportunities tissue
    banking
  • Weaknesses Lack of imaging and information
    standards
  • Weaknesses Pathologists lack of partnership
    with Radiology
  • Weaknesses Fear of change from traditional
    practice roles
  • Weaknesses Decreasing practice margins, poor
    funding base (except maybe for tissue banking)
  • Opportunities Digital pathology and Tissue
    Banking
  • Opportunities - Pathologist as data miner and
    role in bioinformatics
  • Threats EMR Radiology
  • Threats Lack of Support for Molecular
    Diagnostics, Emerging Tech
  • Threats Lack of integration between AP and CP
  • Threats Significant under-investment in
    Training
  • Conclusions

4
Outline
  • SWOT Analysis for Oncology Informatics
  • Strengths Strong funding base, e.g. clinical
    trials and biomarkers
  • Strengths - Very common disease hence
    philanthropy is everywhere
  • Strengths 70 of pathology work is oncology
    related
  • Weaknesses Lack of solid information systems
    (commercial)
  • Weaknesses Lack of integration w/ Radiation Onc
    (60 OP visits)
  • Weaknesses Fear of change from traditional
    practice roles
  • Opportunities caBIG and NIH Roadmap Initiatives
  • Opportunities Multispecialty nature touches all
    of medicine (Path, Med, Surg, Radiology,
    Radiation Onc, Pharmacy, etc)
  • Threats Lack of a tailored EMR (except 1
    company)
  • Threats Funding cap after run up
  • Threats Reimbursement in Med Onc under siege
    pressures informatics investment
  • Threats Lack of investment in training
    (dramatic)
  • Conclusions

5
SWOT Analysis for Pathology
  • Strengths
  • Imaging has matured and whole slide imaging is a
    reality hence digital pathology is emerging
    look at radiology today!!!
  • American Board of Pathology whole slides for AP
    boards
  • CAP Virtual Slides Seminars
  • US Labs Virtual Image Analysis
  • Trestle (formerly InterScope) Has a complete
    workflow design with HL7 messaging and API to
    allow LIS interact with imaging context and
    content
  • Web enabling pathology reporting
  • Telepathology as model systems for Reporting
  • Enhanced Pathology Reporting is being used as a
    way to compete for laboratory testing

6
SWOT Analysis for Pathology
  • Weaknesses
  • Lack of Imaging and Information Standards
  • Need to promote imaging standards
  • HL7 RIM (version 3) provides an object model
    for true information transport
  • SNOMED need a reference terminology tower of
    Babel
  • CAP Cancer Checklists now a requirement for
    ACOS certification
  • Synoptic reporting too slow for uniform
    adoption and integration
  • Fear of Loss of Current Comforts
  • Pathologists need to think forward to their
    future roles as information mangers and knowledge
    engineers instead of keeping in the comfort
    zone as diagnostician only This is a critical
    problem today.
  • Pathology leadership need to really come to
    understand how the practice is evolving
    Embracing Practice Innovation is KEY!!!

7
SWOT Analysis for Pathology
  • Opportunities
  • Digital pathology (concentrating on Advancing
    Practice only)
  • Quality assurance true peer review, perhaps
    by experts
  • Second opinions on all new diagnoses of cancer,
    metabolic diseases and rejection in
    transplant/cellular therapies
  • Access to archival images key to management of
    transplant and cellular therapies
  • A platform for accomplishing
  • Quantitative Analysis for Immunohistochemistry
  • Content Based Image Retrieval check your
    diagnosis against a collaborative telemicroscopy
    system
  • Advance new imaging methodologies to innovate
    pathologist role
  • Proteomic based analysis of whole sections
    (Vanderbilt)
  • Move to eliminate errors in pathology diagnostics
  • Pathologist as data miner
  • Evolution from data manager to knowledge
    engineer/data miner
  • Less time spent on generating the test result and
    more time integrating it with other data sources

8
SWOT Analysis for Pathology
  • Threats (concentrating on Advancing Practice
    only)
  • Electronic Medical Record Systems (EMR)
  • We are becoming lazy in Pathology and our
    outsourcing the delivery of lab data to the EMR
  • Need to re-up our commitment to be the curator of
    lab data and its representation to the patients,
    doctors, specialists and health care
    professionals we server
  • Radiology and PACS (Picture ArChiving Storage)
  • There is intense concentration on the micron to
    millimeter space
  • The big radiology vendors (digital radiology and
    PACS) are starting to claim and own the
    diagnostic imaging space
  • The distinction between radiology based cellular
    imaging and pathology diagnostics at the sub
    millimeter level is blurring
  • Pathologist must get involved in diagnostic
    imaging initiatives
  • Lack of Integration Between AP and CP
  • We are the biggest problems
  • Need to think about integrated patient disease
    centric reports

9
Pathology and Oncology SWOT AnalysisConclusions
  • MJBs 5 rules to building a stronger future for
    Pathology Oncology
  • Try to become a better listener.
  • Ask the stupid questions you are afraid to ask
    and remember you are always a student and have a
    lot to learn, be curious!!!
  • Realize that change is your friend even when it
    rattles your bones and shakes your confidence.
  • Learn to publish and only do this in open source
    journals
  • Share everything you produce through websites,
    data sharing sites and NIH Roadmap Initiatives.

10
Informatics Challenges
  • Introduction to AP- CP-LIS Integration Problems
  • Informatics Challenges in Molecular Pathology
  • The AP vs. CP issue
  • Where are New Technologies Leading Us?
  • Role of Tissue Banks in Molecular Testing
    Research
  • Molecular Pathology Electronic Medical Record
  • Major Threat Under Investing in Training
  • Major Opportunity NIH Roadmap Initiatives
  • Conclusions

11
Pathology Informatics Opportunities and Challenges
  • Many test-ordering physicians are already facing
    information overload number of patients seen
    also ratcheting upwards in the age of
    personalized medicine
  • Genomics/proteomics testing will exacerbate this
    problem due to volume complexity of info
    generated
  • Information can no longer be presented solely as
    numbers (CP) text (AP) must now begin to
    present images, diagrams, schematics or we will
    lose to EMRs
  • Classic LISs EMRs will be inadequate vehicles
    for displaying complex info generated by new
    pathology
  • We must also integrate our information into the
    handheld and wireless environment to better serve
    our clients

12
The AP/CP Integration Issue
  • Where does The New Pathology lead to
  • Look at trends over the few four decades
  • Increasingly specialty laboratories reporting
    needs are not being met
  • Tissue Typing
  • Hematopathology
  • Cytogenetics
  • Microbiology
  • Immunopathology
  • Molecular Pathology
  • Harder to distinguish which are CP
    (quantitative/numeric result driven) and which
    are AP-like (qualitative/text driven)
  • Vendors have largely not engineered this into
    their solutions
  • Problem is that AP- CP-LIS are not integrated.
  • This is a basic flaw in pathology.

From Gilbertson and Becich, Adv Lab Mgr, 1998
13
Pathology Informatics Opportunities and Challenges
  • CP data is already fully integrated into the CPR
    using HL-7 and in rare instances (why?) LOINC
    these changes have been driven by demands from
    clinicians
  • AP data is largely ignored by EMR/CPR initiatives
    (cell in a chart approach)
  • Biggest Challengemeeting needs of Molecular
    Pathology
  • Structured data entry in surgical pathology
    results ins uncompensated greater work burden
    for labs
  • However, integrated, retrievable, longitudinal
    clinical data provides new opportunities and new
    product lines for labs/pathologists
  • Next challenge is synoptic reporting and image
    capture and integration on the AP side
  • Fundable opportunities on the research side of
    pathology - NCI and NIH Roadmap

14
Informatics Challenges
  • Introduction to AP- CP-LIS Integration Problems
  • Informatics Challenges in Molecular Pathology
  • The AP vs. CP issue
  • Where are New Technologies Leading Us?
  • Role of Tissue Banks in Molecular Testing
    Research
  • Molecular Pathology Electronic Medical Record
  • Major Threat Under Investing in Training
  • Major Opportunity NIH Roadmap Initiatives
  • Conclusions

15
Informatics Challenges in Molecular Pathology (MP)
  • Primary challenge is lack of a information
    systems to meet the diverse needs of MP
  • Molecular Hematopath as a model for The New
    Pathology
  • Informal Survey of Audience about LIS (Lab Info
    Systems)
  • Who uses their CP LIS for Molecular Pathology
    Reporting?
  • Who uses their AP LIS for Molecular Pathology
    Reporting?
  • Who is satisfied with their reports?
  • Secondary Challenge is results reporting in the
    Electronic Medical Record (EMR) or Clinical Data
    Repository (more on this later)
  • Secondary Challenge is also supporting test
    development in a LIMS systems (later as well)

16
The AP vs. CP issue
  • Where does The New Pathology lead to
  • Molecular Hematopathology as the model
  • Need to support bone marrow core and smear data
    with CBCs
  • Support lymph node reports with surface marker
    studies
  • Needs to integrate CP data into complex textual
    reports
  • Need to integrate Molecular Hematopathology data
  • Support microarray data (already at UCSD
    Tillman)
  • Problem is that LIS are not integrated and
    neither are our AP can CP divisions in our
    Departments
  • Molecular Pathology is the New Pathology
  • By working with Informatics we can surmount this
    integration challenge by best practices
  • Pathology Info Molecular Path need to join
    forces!!!

17
Where are New Technologies Leading Us?
  • On a pathway to integrate microarray technology
    into our clinical practice
  • This will result in more complex data management
    as well as analytical needs
  • Examples of this are in the leukemia and
    pediatric tumor space already
  • Work by Staudt Leukemias
  • Work by Triche Pediatric bone/soft tissue
    tumors
  • AMP Molecular Classification of Lymphomas
  • This requires new capabilities not currently
    supported by our LIS systems
  • Need for true information systems for this work

18
Why does Molecular Pathology require a LIS as
well as a LIMS?
  • Laboratory Information System or LIS
  • Addresses customized (standard) workflow and
    billing
  • AP CP systems NOT integrated, grew from billing
  • Historical evolution focused on managing single
    values (CP) and text reports (AP)
  • Hybrid systems that efficiently handle
    quantitative (CP) and qualitative/descriptive
    data (AP) are not available
  • Laboratory Info Management Systems or LIMS
  • Historically used in pharma and biotech for test
    development and validation in research
  • Not focused on billing but information management
  • Allow for data mining and built to support data
    warehouse LIS does not allow this!!!

19
Role of Tissue Banks in Molecular Testing
Research
  • Providing banked controls for disease and
    normal are going to be increasingly critical for
    Molecular Pathology
  • Patients own progression control to provide a
    backdrop for individualized therapeutic
    monitoring is critical in protein, gene and
    cellular therapies
  • Data management and annotation is critical
    value-add to tissue banking feature Cancer
    Biomedical Informatics Grid (caBIG, see
    http//cabig.nci.nih.gov) - open source tool
    development as part of NIH Roadmap (more later)
  • Development/maintenance of longitudinal
    databases, with images are critical often
    neglected-whole slide imaging
  • Tissue banking also provides opportunity for
    Molecular Pathology labs to develop relationship
    with pharma, biotech and nanotechnology research

20
Critical Roles of Tissue Banks and Informatics in
Molecular Pathology
  • Molecular Pathology
  • Biomarker Diagnostics prime location for marker
    development
  • Genomics DNA and RNA expression microarrays
    SNPs
  • Proteomics mass spectroscopy robotic 2D gel
    sampling
  • Epigenomics methylation and other studies
  • Tissue Banking
  • Tumor Banks needed for all of above studies and
    clinical controls
  • Serum and Genomic DNA for proteomic
    epigenomic studies
  • Normal Tissue Banking needed for true controls
    both clinical marker development and research
  • Warm Autopsy Banking needed for rare
    metastatic samples not obtained clinically
  • Informatics
  • Clinical Outcomes Infoneeded for translational
    basic research
  • De-Identified Data research annotation of
    tissues banked
  • Bioinformatics needed for marker development
    and analysis

21
Shared Pathology Informatics Network De-identifica
tion and Autocoding
Record de-identified by de-ID v. 3.3PATIENT
HISTORYThe patient is a AGE-year-old male
with a clinical history of prostate cancer.OSS
PATH-NUMBERlt1gt, DATElt11/12/00gt, PLACE
.________________________________________________
_______________FINAL DIAGNOSISveiw
conceptsPART 1 PROSTATE, LEFT LOBE, NEEDLE
BIOPSY (OSS PATH-NUMBERlt1gt, DATElt11/12/00gt,
PLACE) A. MODERATELY DIFFERENTIATED PROSTATE
ADENOCARCINOMA. GLEASON' S PATTERN 33, SCORE
6, INVOLVING ONE OF FIVE CORES, LESS THAN 2 OF
TISSUE SUBMITTED (see comment).B. NO PERINEURAL
INVASION SEEN.veiw conceptsPART 2 PROSTATE,
RIGHT LOBE, NEEDLE BIOPSY (OSS PATH-NUMBERlt1gt,
DATElt11/12/00gt, PLACE) A. MODERATELY
DIFFERENTIATED PROSTATE ADENOCARCINOMA, GLEASON'
S PATTERN 34, SCORE 7, INVOLVING ONE OF FIVE
CORES, LESS THAN 5 OF TISSUE SUBMITTED.B. NO
PERINEURAL INVASION SEEN.kmrINITIALS kmr
NAME, M.D. Fellow/Chief Resident NAME, MBBS.
M.D.Resident NAME, M.D. NAME MMM VVV
NAME, M.D.DATElt0/2/00gt 1027_________________
______________________________________________OUT
SIDE ACCESSION 2 SLIDES LABELED
PATH-NUMBERlt1gtOUTSIDE NAME RECEIVED
YCONSULT MATERIAL DESCRIPTIONReceived for
consultation from NAME, M.D., are two (2)
consult slideslabeled PATH-NUMBERlt1gt from
PLACE , ADDRESS ,
22
Informatics Challenges
  • Introduction to AP- CP-LIS Integration Problems
  • Informatics Challenges in Molecular Pathology
  • The AP vs. CP issue
  • Where are New Technologies Leading Us?
  • Role of Tissue Banks in Molecular Testing
    Research
  • Molecular Pathology Electronic Medical Record
  • Major Threat Under Investing in Training
  • Major Opportunity NIH Roadmap Initiatives
  • Conclusions

23
Molecular Pathology and the Electronic Medical
Record
  • Turf challenges with the paper record were
    limited tab in chart market lab and hardcopy
    reports
  • Situation now more fluid with the EMR pathology
    information managers may need to fight for
    pathologys electronic turf especially in the
    case of Molecular Path
  • Molecular Pathologys special needs are not
    represented in current vendor products (in fact
    much the same for all)
  • All lab data should flow through the Pathology
    Department validation, integration, and
    formatting
  • Not happening due to EMR control outside of
    Pathology
  • This is not just an academic concern as central
    lab control of data dis-integrates, new data
    squabbles can be anticipated

24
Informatics Challenges
  • Introduction to AP- CP-LIS Integration Problems
  • Informatics Challenges in Molecular Pathology
  • The AP vs. CP issue
  • Where are New Technologies Leading Us?
  • Role of Tissue Banks in Molecular Testing
    Research
  • Molecular Pathology Electronic Medical Record
  • Major Threat Under Investing in Training
  • Major Opportunity NIH Roadmap Initiatives
  • Conclusions

25
Critical Role of Training
  • API, APIII and Lab InfoTech Summit have provided
    a rich palate of educational opportunities
  • Not nearly enough formal trainees in Pathology
    Informatics nor hybrid trainees in Molecular
    Pathology and Informatics
  • Two trainees with this phenotype have been
    successful
  • Need many more and collaboration between AMP and
    API
  • CAP Foundation has a Informatics Fellowship
    program
  • Molecular Genetic Pathology Fellowship program
  • Are there any informatics requirement?
  • Multiple Issues - We need to work on this
    together
  • Abundant translational basic research opps

26
Informatics Challenges
  • Introduction to AP- CP-LIS Integration Problems
  • Informatics Challenges in Molecular Pathology
  • The AP vs. CP issue
  • Where are New Technologies Leading Us?
  • Role of Tissue Banks in Molecular Testing
    Research
  • Molecular Pathology Electronic Medical Record
  • Major Threat Under Investing in Training
  • Major Opportunity NIH Roadmap Initiatives
  • Conclusions

27
Informatics, Molecular Pathology the NIH
Roadmap
caBIG
cabig.nci.nih.gov
28
caBIG Molecular Pathology Informatics Support
  • Microarray Repositories
  • caArray annotation of microarray data, for data
    sharing and integration (Directors Challenge
    data)
  • Genome Annotation
  • GeneMiner genome ontology miner
  • Proteomics Informatics (LIMS tools)
  • Pathway Tools (tie genome and proteome)
  • Translational Tools (enable development)
  • Data Analysis and Statistical Tools
  • caWorkBench analysis tools for data exploration

29
National Biospecimen Network (NBN) Initiative
  • NCI and C-Change (formerly National Dialogue on
    Cancer) initiative in partnership with Industry
  • Goal Provide tissues with high degree of
    clinical annotation as well as analysis center
    approach to additionally providing omic data
    sets
  • Not for profit activity with national
    distribution mechanism/governance
  • Based on Best Practices in Tissue Bank report
    by Rand Corporation
  • University of Pittsburgh and PCABC profiled as
    best practice in academia
  • For full report see http//www.rand.org/publicatio
    ns/MG/MG120/
  • Blueprint for NBN publicly available at
    http//www.ndoc.org/about_ndc/reports/pdfs/FINAL_N
    BN_Blueprint.pdf
  • Pilot program initiated with Prostate SPOREs
  • Deputy Director (Anna Barker) sill interested in
    a community based tissue banking pilot (hence
    discussion that follows)

30
Informatics Challenges
  • Introduction to AP- CP-LIS Integration Problems
  • Informatics Challenges in Molecular Pathology
  • The AP vs. CP issue
  • Where are New Technologies Leading Us?
  • Role of Tissue Banks in Molecular Testing
    Research
  • Molecular Pathology Electronic Medical Record
  • Major Threat Under Investing in Training
  • Major Opportunity NIH Roadmap Initiatives
  • Conclusions

31
Conclusions
  • Molecular Pathology Pathology Informatics have
    fertile ground for collaboration to solve the
    AP/CP integration issues
  • Both are ASIP divisions with growing membership
  • Both are new, innovative, attractive areas of
    Pathology
  • Common problems in search of solutions LIS
    LIMS
  • To solve the AP CP schism, partnership is key
  • Training is at a critical nexus for both
    organizations
  • Need support from Pathology Leadership
  • Continue to leverage the funding from NIH Roadmap
    and NCI to move forward

32
Pathology Informatics Publications NOTE
Please e-mail me at becich_at_pitt.edu if you want
PDFs
  • Yagi Y, Ahmed I, Gross W, Becich MJ, Demetris AJ,
    Wells A, Wiley CA, Michalopoulos GK, Yousem SA,
    Barnes B, Gilbertson JR. Webcasting pathology
    department conferences in a geographically
    distributed medical center. Hum Pathol. 2004
    Jul35(7)790-7.
  • Zheng L, Wetzel AW, Gilbertson J, Becich MJ.
    Design and analysis of a content-based pathology
    image retrieval system. IEEE Trans Inf Technol
    Biomed. 2003 Dec7(4)249-55.
  • Crowley RS, Gadd CS, Naus G, Becich M, Lowe HJ.
    Defining the role of anatomic pathology images in
    the multimedia electronic medical record--a
    preliminary report. Proc AMIA Symp 2000161-5.
  • Becich, M.J. The role of the Pathologist as
    tissue refiner and data miner The impact of
    functional genomics on the modern pathology
    laboratory and the critical roles of Pathology
    Informatics and Bioinformatics. Molec Diag.
    5(4)287-299, 2000.
  • Landman A, Yagi Y, Gilbertson J, Dawson R,
    Marchevsky A, Becich MJ. Prototype web-based
    continuing medical education using FlashPix
    images. Proc AMIA Symp. 2000 462-6.
  • Becich, M.J.. Information management moving from
    test results to clinical information. Clin
    Leadersh Manag Rev. 2000 Nov-Dec14(6)296-300.
  • Gilbertson, J. Becich, M.J. Imaging in
    Pathology. Adv Lab Med Prof 8(1) 55-58, 1999.
  • Dawson R, Gilbertson JR, Kim SJ, Becich MJ.
    Pathology Imaging on the Web Extending the Role
    of the Pathologist as Educator to Patients.
    Pathology Clinics of North America? Clinics in
    Laboratory Medicine, 19(4), Dec 1999, 849-66.
  • Gilbertson, J. and Becich, MJ. Perspectives in
    Pathology Cancer Information Therapy and the
    Need to Transform the Pathology Report. Adv Lab
    Mgr June 1998.
  • Wetzel, A.W., Crowley, R., Kim, S.J., Dawson, R.,
    Zheng, L., Joo, Y.M., Yagi, Y., Gilbertson, J.,
    Gadd, C.,. Deerfield, D.W., Becich M.J.
    Evaluation of prostate tumor grades by content
    based image retrieval. 27th AIPR Workshop
    Advances in Computer Assisted Recognition,
    Washington D.C., October 16, 1998., SPIE
    Proceedings, Vol. 3584, pages 244-252.
  • Becich, M.J., Gilbertson, J. Perspectives in
    Pathology - Cancer information therapy and the
    pathology report. Adv Lab Med Prof 611-12, 14,
    1998.


33
Bioinformatics Publications NOTE Please e-mail
me at becich_at_pitt.edu if you want PDFs
  • Zheng L, Wetzel AW, Gilbertson J, Becich MJ.
    Design and analysis of a content-based pathology
    image retrieval system. IEEE Trans Inf Technol
    Biomed. 2003 Dec7(4)249-55.
  • Gupta D, Saul M, Gilbertson JR. Evaluation of a
    De-identification Software Engine to Share
    Pathology Reports and Clinical Documents for
    Research. AJCP, Feb 2004.
  • Berman JJ, Datta M, Kajdacsy-Balla A, Melamed J,
    Orenstein J, Dobbin K, Patel A, Dhir R, Becich
    MJ. The tissue microarray data exchange
    specification implementation by the Cooperative
    Prostate Cancer Tissue Resource. BMC
    Bioinformatics. 2004 Feb 275(1)19.
  • Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu
    L, McDonald C, Thomas R, Dhir R, Chandran U,
    Gilbertson J, Finkelstein S, Michalopoulos G,
    Becich MJ, and Luo JH. Gene Expression
    Alterations in Prostate Cancer Predicting Tumor
    Aggression and Preceding Development of
    Malignancy. (In press, J Clin Oncol).
  • Gilbertson JR, Gupta R, Nie Y, Patel AA, Becich
    MJ. Automated Clinical Annotation of Tissue Bank
    Specimens. (in press, MedInfo)
  • Melamed J, Datta MW, Becich MJ, Dhir R,
    Orenstein, JM, Silver S, Fidelia-Lambert M,
    Kadjacsy-Balla A, Macias V, Walden PD, Bosland
    MC, Berman JJ, and the CPCTR. The Cooperative
    Prostate Cancer Tissue Resource (CPCTR) A
    Specimen and Data Resource for Cancer Researchers
    (in press, Clinical Cancer Research).
  • Becich MJ, Gilbertson JR, Gupta D, Grzybicki DM
    and Raab, SS. Patient Safety and Healthcare
    Research The Critical Role of Pathology
    Informatics in Error Reduction and Quality
    Initiatives. (in press, Clin Lab Med).
  • Yagi Y, Ahmed I, Gross W, Becich, MJ, Demetris
    AJ, Wells A, Wiley C, Michalopoulos G, Yousem S,
    Barnes B, Gilbertson J. Web-casting Pathology
    Department Conferences in a Geographically
    Distributed Medical Center (in press, Mod
    Pathol).
  • Mitchell KJ, Becich MJ, Berman JJ, Chapman WW,
    Gilbertson J, Gupta D, Harrison J, Legowski E,
    and Crowley RS Implementation and Evaluation of
    a Negation Tagger in a Pipeline-based System for
    Information Extraction from Pathology Reports
    (in press, Med Info).
  • Li S, Becich MJ, Gilbertson J. Microarray Data
    Mining Using Gene Ontology. (in press, Med Info)
  • Ma C, Becich MJ and Gilbertson JR. Comparison of
    analysis methods, feature reduction and tissue
    processing on the supervised classification of
    benign and tumorous prostate tissue samples. (in
    press, Bioinfo.)
  • Lyons-Weiler, J., Patel, Satish, S., Becich,
    M.J., Godfrey, T. An Unusual Form of
    Differential Expression in Cancers. (in press,
    Bioinfo).

34
Support APIII
10th Annual Meeting 2005 Meeting Aug
24-26th Themed on Practical Tools for
Pathology/Oncology Pathology Imaging Jamboree,
HL7 and SNOMED in Practice, HIPAA, Honest Broker
and IRB Practical Approaches, caBIG as a Change
Element, Lab Portals, Impact of EMRs, Vendor
Visions of the Future New Venue Lake Tahoe,
CA Granlibakken Conf Ctr Abstract
Sessions Trainee Travel Awards http//apiii.upmc.e
du
35
History from APIII 1997
http//apiii.upmc.edu/archive/1997/talks/becich/sl
d001.htm
36
History from APIII - 1999
http//apiii.upmc.edu/archive/1999/talks/e2/sld001
.htm
37
History from APIII - 2002
http//apiii.upmc.edu/archive/2002/Path-in-Onc-Inf
o-APIII2002-MBv3-091802x.htm
38
APIII On Line Archive
http//apiii.upmc.edu/live/index.html
39
Center for Pathology Informatics Benedum
Oncology Informatics Center
  • Programming Support
  • Becky Boes
  • Tom Harper
  • John Milnes
  • Kelli Richter
  • Web Services
  • Valerie Monaco, PhD, MS HCI
  • Aab Arnold Dan Goldberg
  • Network and Server Services
  • Gary Burdelski
  • Ryan Mitchell
  • Help Desk and Application Support
  • Chuck Susanin
  • Joel Young (Mac Support)
  • Mark Michalski (PC support)
  • Cerner CoPath AP LIS
  • Bill Gross
  • Anthony Piccoli
  • Frank Losos
  • Rick Nestler Lisa Devine
  • Support staff of 12 (18 sites)
  • Misys FlexiLab CP LIS
  • Gary Blank, PhD
  • Jim Harrison, MD PhD
  • Support Staff of 8 (12 sites)
  • Cerner PathNet LIMS
  • Mike Sendek
  • Jeff Schullo
  • Support staff of 3 (5 labs)
  • Quest Joint Venture Support
  • Mary Mueller

40
Benedum Oncology Informatics Center and Center
for Pathology Informatics
  • Bioinformatics and Analysis Group
  • John Gilbertson, MD
  • James Lyons-Weiler, PhD
  • Deep Bhattacharya, (Grad St)
  • Uma Chandran, MS
  • Cathy Ma (Grad Student)
  • Cancer Registry
  • Sharon Winters, MS
  • Heidi Gianella
  • Susan Urda
  • Clinical Trials
  • Doug Fridsma, MD PhD
  • Mike Davis
  • Bill Gross
  • De-Identification Software
  • Melissa Saul, MS
  • Organ Specific Databases
  • Rajnish Gupta
  • Yimin Nie, MD
  • caTIES, Vocabularies and CDEs
  • Rebecca Crowley, MD
  • Kevin Mitchell, MS
  • Tissue Banking Info System
  • Michelle Bisceglia
  • Vicky Chu
  • Rajiv Dhir, MD
  • Ashok Patel, MD
  • Susan Urda
  • Tissue Microarray Info Sys EDRN
  • Harpreet Singh
  • PGED and Gene Ontology tools

41
End of Talk e-mail me at becich_at_pitt.edu if you
have questions/clarifications not covered in the
discussion. NOTE Please e-mail if you want PDFs
of articles or presentations.
  • Thank you for the invitation to participate in
    the Lab Infotech Summit Meeting.

42
Organizational Chart
Clinical Support
Translational Research
Enterprise Research Tools
Imaging Telepathology
National Member Teaching Organizations
Patient Safety Informatics
43
Molecular Imaging
  • Intro to Pathology Informatics
  • Opportunities and Challenges
  • Informatics Challenges in Molecular Pathology
  • The AP vs. CP issue
  • Where are New Technologies Leading Us?
  • Role of Tissue Banks in Molecular Testing
    Research
  • Molecular Pathology Electronic Medical Record
  • Molecular Imaging Proteomics
  • Major Threat Under Investing in Training
  • Major Opportunity NIH Roadmap Initiatives
  • Conclusions

44
Molecular Imaging Threat
  • IHC, ISH and Molecular Testing and Proteomics
  • Detect protein distribution in tissue without
    antibodies
  • Uses modification of mass spectroscopy technology
    that has been used in clinical pathology labs for
    years
  • The squeeze will come from two directions
  • Proteomics based tissue mass spectroscopy (next
    slide)
  • Radiology based biological imaging methods (more
    on this next year) focused on micron rather than
  • What can we do about it in Pathology?
  • Change the attitude of pathologists (anatomic,
    clinical molecular pathologists) to champion
    these new diagnostic technologies
  • Break down the 6 foot thick concrete walls btwn
    AP/CP

45
Proteomics BasedMolecular Tissue Imaging
  • Proteomics based Tissue Imaging Needs a Digital
    Imaging Platform whole slide imaging can
    provide this
  • Allows for dynamic probing of cells and tissues
    for protein expression at micron (sub-millimeter)
    level
  • Will be new tool for pathologists (hopefully)!!!

46
Molecular Pathology, Informatics Imaging - Key
Roles in Biomarker Development
  • Pathologic, Genomic, Proteomic Analyses on
    Patients Tumors
  • Clinical Information Outcomes
  • Biomarker Patho(Bio) Informatics
  • Imaging will be key in the mapping DNA, RNA and
    proteins in the context of disease to create new
    tools for theranostics

Pathologic Analysis (Phenotype)
Bioinformatics
Bioinformatics
Bioinformatics
Genomics (Genotype)
Proteomics
47
Short Intro to Pathology Informatics
  • Pathology Informatics history
  • Initiated 70s w/ computerization of the CP labs
  • Automated Information Management in the Clinical
    Laboratory (AIMCL) launched in 1983 by Bruce
    Friedman
  • Focused on system selection and lab management
  • CP focused initially diversified towards AP
    bioinfo
  • APIII launched in 1996 (Univ of Pittsburgh)
  • CAPF creates Informatics Awards in 1997
  • Association for Path Info launched in 2000
  • AIMCL becomes LabInfoTech Summit in 2003

48
Over 50 Pathology Programs with Informatics
Division
  • Pathology Partners Kuo Cheng
  • Rutgers Dave Foran
  • Scripps Memorial John Spinosa
  • Stanford University Vacant
  • Thomas Jefferson Univ. DeBaca
  • Univ. Arizona - Weinstein, Klein
  • UCLA George Thomas
  • Univ. Chicago Vacant
  • UMDNJ Tony Grygotis
  • Univ. Maryland - Vacant
  • Univ. Michigan- Bruce Friedman
  • Univ. Minnesota Don Connelly
  • Univ. Pennsylvania Mike Feldman
  • Univ. Pittsburgh Crowley, Gilbertson, Monzon
  • Univ. Rochester Scott LaPoint
  • Univ. TX Houston Dan Cowan
  • Univ. Toronto Aaron Pollett
  • Univ. Virginia Harrison, Post
  • Univ. VT Mike Gagnon
  • Allegheny WP Hospital - Vacant
  • Armed Forces Inst. Path. Bruce Williams
  • Brigham Womens David Beckwith
  • Brown University Vacant
  • Chilton Memorial Hosp Dwayne Breining
  • Cleveland Clinic Wally Henricks
  • Creighton University Jim Healy
  • Dana Farber Cancer Center Mark Rubin
  • Duke University Rajesh Dash
  • East Carolina University Paul Catrou
  • Emory University - Hunter Hardy
  • Fred Hutchinson Cancer Ctr. Vacant
  • Florida State University Ed Klatt
  • Geisinger Health System Jeff Prichard
  • Harvard Univ. Dave Weinberg
  • Henry Ford Mark Tuthill
  • John Hopkins University Bob Miller
  • Massachusetts General Hospital Ul Balis
  • MD Anderson Langford, Mark Routbort

NOTE CAPF Travel Awardees 14 active as
faculty in Pathology Informatics.
NOTE At least 10 programs are seeking
Pathology Informatics Faculty
49
Pathology Informatics Where Should We Focus
  • AP- CP-LIS Integration Problems
  • Informatics Challenges in Molecular Pathology
  • The AP vs. CP issue
  • Where are New Technologies Leading Us?
  • Role of Tissue Banks in Molecular Testing
    Research
  • Need more involvement in Electronic Med Record
  • Major Threat Under Investing in Training and
    Certification in Informatics (e.g. Pathology)
  • Major Opportunity NIH Roadmap ONCHIT
  • Conclusions APIII, LabInfoTech and API are
    having a major impact thanks to your support!!!

50
Association for Pathology Informatics
(API)http//www.pathologyinformatics.org
to advance the field of pathology informatics as
an academic and a clinical subspecialty of
pathology.
51
API Membership Benefits to Individuals
  • Recognition as member of Pathology Informatics
    professional discipline
  • Discounts at APIII, Lab InfoTech meetings
  • Attending one meeting alone offsets cost of dues
  • Members-only Listserv
  • Managed at ASIP (advertisement-free)
  • Peer networking and education (real time)
  • Professional development opportunities
  • Access to open source tools
  • TMA XML data exchange standard
  • Comprehensive abbreviations repository
  • Digital imaging standards efforts for pathology

52
API and the TMA XML Data Exchange Format
  • TMA slide set contains
  • Cancer tissue from radical prostatectomy
    specimens of 299 patients
  • Control non-neoplastic tissue from benign
    prostatic hyperplasia (BPH)
  • Control non-diseased tissue from organ donor
    prostates
  • Cores from prostate cancer cell lines
  • TMA XML Data Exchange Format

TMA XML Data Exchange Format for Core N52
  • ltrecordgt
  • ltIMS_Case_Identifiergt1033477551lt/IMS_Case_Identif
    iergt
  • ltLocation_CodegtN52lt/Location_Codegt
  • ltRacegtCaucasianlt/Racegt
  • ltYear_of_Birthgt1923lt/Year_of_Birthgt
  • ltYear_of_Diagnosisgt1991lt/Year_of_Diagnosisgt
  • ltYear_of_Prostatectomygt1992lt/Year_of_Prostatectom
    ygt
  • ltIs_Residual_Carcinoma_PresentgtYeslt/Is_Residual_Ca
    rcinoma_Presentgt
  • ltMost_Prominent_Histologic_Typegtadenocarcinoma
    NOS aka acinarlt/Most_Prominent_Histologic_Typegt
  • ltGleason_Primary_Gradegt4lt/Gleason_Primary_Gradegt
  • ltGleason_Secondary_Gradegt3lt/Gleason_Secondary_Grad
    egt
  • ltGleason_Sum_Scoregt7lt/Gleason_Sum_Scoregt
  • ltNumber_of_Nodes_Examinedgt11lt/Number_of_Nodes_Exam
    inedgt
  • ltNumber_of_Nodes_Positivegt0lt/Number_of_Nodes_Posit
    ivegt
  • ltDistant_Mets__1_at_Time_of_DiagngtNonelt/Distant_Me
    ts__1_at_Time_of_Diagngt
  • ltpT_StagegtpT3alt/pT_Stagegt
  • ltpN_StagegtpN0lt/pN_Stagegt
  • ltpM_StagegtpM0lt/pM_Stagegt
  • ltVital_StatusgtAlivelt/Vital_Statusgt
Write a Comment
User Comments (0)
About PowerShow.com